Market Overview

Benzinga's Volume Movers

Share:
Related CNAT
Conatus Announces Initial Baseline Data From Phase 2b POLT-HCV-SVR Clinical Trial of Emricasan Confirming Activity of Relevant Mechanisms and Opportunity for Histological Improvement
Pandora, Sohu.com, Infinity Pharmaceuticals Lead Friday's After-Hours Movers
Related GALT
Morning Market Gainers
Wednesday Morning Movers

Conatus Pharmaceuticals (NASDAQ: CNAT) shares moved up 35.20% to $13.25 after jumping 57.05% on Thursday. The volume of Conatus Pharmaceuticals shares traded was 6786% higher than normal.

Galectin Therapeutics (NASDAQ: GALT) shares rose 21.19% to $16.35. The volume of Galectin Therapeutics shares traded was 3091% higher than normal. Galectin reported that it has sold 2.39 million shares at an average price of $9.99 per share.

Intercept Pharmaceuticals (NASDAQ: ICPT) shares climbed 41.73% to $391.00. The volume of Intercept Pharmaceuticals shares traded was 2251% higher than normal. Citigroup lifted the price target on the stock from $60.00 to $400.00, while Bank of America raised the price target from $81.00 to $872.00.

American Pacific (NASDAQ: APFC) surged 18.97% to $46.54. The volume of American Pacific shares traded was 1202% higher than normal. American Pacific agreed to be acquired by H.I.G. Capital LLC.

Posted-In: volume moversNews Intraday Update Markets Movers

 

Related Articles (APFC + CNAT)

Get Benzinga's Newsletters